Vitamin D and Omega-3 Trial to Prevent and Treat Diabetic Kidney Disease [ANCILLARY OF 700049031]
Phase of Trial: Phase IV
Latest Information Update: 22 Mar 2018
At a glance
- Drugs Colecalciferol (Primary) ; Omega-3-acid ethyl esters (Primary)
- Indications Diabetic nephropathies
- Focus Therapeutic Use
- Acronyms VITAL-DKD
- 16 Mar 2018 Status changed from active, no longer recruiting to completed.
- 10 Jun 2017 Biomarkers information updated
- 13 May 2016 Planned primary completion date changed from 1 Jun 2016 to 1 Dec 2017.